Webster Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Webster Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-443	Closed	-$26K	–	607
2016 Q4	$26K	Buy	+443	New	+$27.3K	﹤0.01%	419

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Webster Bank's XBI Position: Q1 2017 in Review

Webster Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2017, closing a stake of 443 shares — an estimated $26K sold.

Webster Bank first reported a position in XBI in Q4 2016 and held it in 1 quarter. The position peaked at $26K in Q4 2016. 292 funds tracked by Wall St. Rank hold XBI as of Q1 2017.

Webster Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2017 after selling out during the quarter.
Webster Bank sold 443 State Street SPDR S&P Biotech ETF shares in Q1 2017, an estimated $26K.
Webster Bank first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 1 quarter.
Webster Bank's State Street SPDR S&P Biotech ETF position peaked at $26K in Q4 2016.
292 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2017.

Based on Webster Bank's 13F filing for Q1 2017, filed 1 May 2017.